Anti-apoptosis mechanisms in malignant gliomas

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
David S ZieglerMark W Kieran

Abstract

Malignant gliomas are characterized by an intrinsic resistance to apoptosis. Increasing evidence suggests that this is a fundamental mechanism by which gliomas evade elimination when treated with both conventional and targeted therapies. In this review, we describe the multiple anti-apoptotic signals that have been demonstrated to be active in malignant gliomas. We describe the preclinical evidence that suggests that targeting those signaling anomalies can increase tumor responsiveness and enhance the elimination of gliomas in preclinical models. We discuss recent advances in translating pro-apoptotic compounds to clinical trial, and the potential for implementing agents that target the apoptotic pathway as a strategy for improving the outcomes for patients with high-grade gliomas.

References

Jan 17, 1995·International Journal of Cancer. Journal International Du Cancer·A GuhaC D Stiles
Jun 5, 1998·FEBS Letters·J RiegerM Weller
Apr 13, 1999·Biochemical and Biophysical Research Communications·S FrankH K Schackert
Nov 2, 1999·Biochemical and Biophysical Research Communications·Z ChenT Tsuruo
Jan 11, 2001·The New England Journal of Medicine·L M DeAngelis
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Medical Research Council Brain Tumor Working Party
Apr 3, 2001·Nature Medicine·D LawrenceA Ashkenazi
Feb 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arnab ChakravartiJay S Loeffler
Mar 5, 2002·Nature Medicine·Vladimir J N BykovGalina Selivanova
Jun 27, 2002·British Journal of Cancer·F E McDonaldH W W Potts
Sep 10, 2002·Chemotherapy·Patrick GuensbergBurkhard Jansen
Apr 3, 2003·Nature Reviews. Cancer·Clemens A Schmitt
Nov 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Joshua B RubinRosalind A Segal
Nov 25, 2003·Oncogene·Alexei DegterevJunying Yuan
Nov 26, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeremy N RichHenry S Friedman
Jan 6, 2004·Science·Lyubomir T VassilevEmily A Liu
Jan 28, 2004·Cell·Nika N Danial, Stanley J Korsmeyer
Jan 30, 2004·Cancer Immunology, Immunotherapy : CII·Klaus-Michael Debatin
Feb 5, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniela MateiMeei-Huey Jeng
Sep 9, 2004·Science·Loren D WalenskyStanley J Korsmeyer
Sep 24, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Craig W HendrixUNKNOWN AMD3100 HIV Study Group
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Dec 9, 2004·Biochimica Et Biophysica Acta·Jason O'NeillDavid M Hockenbery
Jan 28, 2005·Journal of Neuro-oncology·Joachim P Steinbach, Michael Weller
Feb 16, 2005·Apoptosis : an International Journal on Programmed Cell Death·V K PuduvalliA P Kyritsis
Feb 25, 2005·Blood Cells, Molecules & Diseases·Matthias HoldhoffPhilipp le Coutre
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Helen AthanassiouPantelis Karageorgis
May 20, 2005·Nature·Tilman OltersdorfSaul H Rosenberg
Jun 16, 2005·Journal of the National Cancer Institute·Daphne A Haas-KoganDavid Stokoe
Jun 21, 2005·Nature Reviews. Cancer·Shoshana KleinAlexander Levitzki
Jul 7, 2005·The Journal of Biological Chemistry·Vladimir J N BykovKlas G Wiman
Jul 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Evanthia GalanisUNKNOWN North Central Cancer Treatment Group

❮ Previous
Next ❯

Citations

Jun 23, 2009·Cancer Chemotherapy and Pharmacology·J Lee VillanoLinda R Bressler
Apr 24, 2010·Molecular Neurobiology·Bartlomiej B OrdysIan R Whittle
Sep 19, 2012·Journal of Signal Transduction·A K M Mahbub HasanKen-Ichi Sato
Sep 18, 2012·PloS One·Yuntao LuXiaozhong Qiu
Jul 23, 2014·PloS One·Pasquale SimeoneSaverio Alberti
Jan 14, 2009·World Journal of Gastroenterology : WJG·Chun Feng LeeKuan Rong Lee
Dec 15, 2010·Experimental & Molecular Medicine·You Jung KangKyeong Sook Choi
Apr 15, 2014·Journal of Neuro-oncology·Ruth F DeightonJames McCulloch
Jun 27, 2013·Apoptosis : an International Journal on Programmed Cell Death·Isabelle Vanessa MohrenzDonat Kögel
Apr 27, 2013·Expert Review of Anticancer Therapy·Brian M AlexanderPatrick Y Wen
Aug 25, 2015·Neoplasia : an International Journal for Oncology Research·Irina KiprianovaDonat Kögel
May 13, 2009·Pediatric Blood & Cancer·Betty Herrington, Mark W Kieran
Aug 28, 2009·Journal of Cellular Physiology·Claudia Alexandra DumitruErich Gulbins
Oct 26, 2010·Biochimica Et Biophysica Acta·Liam PorttMichael T Greenwood
Jan 27, 2015·Archives of Toxicology·Waseem Ahmad SiddiquiHaseeb Ahsan
Jun 18, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Sheng-Feng LuBing-Mei Zhu
Oct 16, 2016·Journal of Neurosurgery·Eugene J VaiosJorg Dietrich
Dec 8, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jason W Locasale, Benjamin J Zeskind
Feb 2, 2017·The Journal of Clinical Investigation·Satoru Osuka, Erwin G Van Meir
Nov 21, 2012·Integrative Cancer Therapies·Kenneth RachlinGarret Yount
Dec 21, 2017·BioMed Research International·Larisa RyskalinFrancesco Fornai
Jul 7, 2018·Frontiers in Pharmacology·Yi-Pu FanHong-Chao Pan
Jun 20, 2018·Cells·Timothy E YapMaria Francesca Cordeiro
May 14, 2019·International Journal of Oncology·Iris Maria ForteAntonio Giordano
Nov 20, 2016·Journal of Biomedical Science·Che-Chia HsuJian-Ying Chuang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Biochimica Et Biophysica Acta
Talene A Yacoubian, David G Standaert
© 2021 Meta ULC. All rights reserved